Elanco (ELAN) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Elanco · Health Care · ref. ETF XLV · 58 calls · price $24.49
What the company does: Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
📈 Elanco (ELAN) stock price
$24.49+32.7% over range
Aug 28, 25low $17.35 · high $26.84Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
83% recommend buying · 6 analysts
📊 JPI status : Elanco has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 ELAN price target & analyst consensus — price $24.49
The price target · all analysts combined (6 targets)
Highest target · 1 firm of 6$33+34.7%
Median target · of 6 targets$30.5+24.5%
Lowest target · 1 firm of 6$26+6.2%
Current price$24.49
Where these 6 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
6100%
$26 ↔ $33
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: UBS — 63% of its targets hit on this sector (119 calls tested). It aims for $33 (+35 %), call made on August 7, 2026, maturing on August 7, 2027 (21 d ago).
The 2 reliable analysts
$32.50+33 %
The 4 other firms
$30+23 %
How to read it: the 2 reliable firms are not filtered by optimism — 2 aim above the price, 0 below, hence their $32.50 median. “The 4 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 6 ratings (last 6 months)
Strong Buy00%
Buy583%
Hold117%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 ELAN price target all
All 58 calls, one by one, with our verdict on each firm.
→ See all 58 targets, analyst by analyst💡 The best analysts on ELAN most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in ELAN? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Elanco? The JPI assistant answers using our backtest data.
📈 Elanco fundamentals: valuation, margins & growth › open the full page
P/E —Net margin -4.0 %Revenue growth +10.2 %Not (yet) profitable
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. -2 %
2023
Rev −0%
2024
Rev +0%
2025
Rev +6%Profit −169%
🏛️ Elanco insider buying: who's buying and how much › open the full page
7 insiders bought7 buys / 6 mo $1.7M👥 Cluster buy
🔎 Detailed analyses
✅ Historical analyst reliability on ELAN
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Citigroup ↗ | 100% | +41.3% | 2 |
| Stifel ↗ | 80% | +75.2% | 10 |
| UBS ↗ | 80% | +58.8% | 5 |
| Barclays ↗ | 67% | +31.3% | 9 |
| B of A Securities ↗ | 67% | +5.8% | 3 |
| Goldman Sachs ↗ | 44% | -6.1% | 9 |
| Morgan Stanley ↗ | 38% | -17.9% | 8 |
📊 What $1,000 invested in Elanco would be worth › open the full page
In short — $1,000 invested in Elanco 10 years ago would be worth $722 today, i.e. -4%/yr on average. Best year: 2025 (+88%), worst: 2022 (-57%). Price performance, excluding dividends.
If I'd invested $1,000 in Elanco
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $2,054 | +105% |
| 3 years ago | $2,014 | +101% |
| 5 years ago | $802 | -20% |
Return by year (Elanco)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +9% | $1,093 (+9%) |
| 2025 | +88% | $2,054 (+105%) |
| 2024 | -20% | $1,652 (+65%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Elanco
Loading news…
📋 All analyst calls on ELAN
Filtered on — · ✕ show all
▲ Buy · 🎯$33
Price at call : $22.12 — upside +49%
Today : $24.49 — upside +35%
🎯 on ELAN : 100% (4 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
in progress (365j)
matures : Aug 6, 27
matures : Aug 6, 27
▲ Overweight · 🎯$30
Price at call : $22.12 — upside +36%
Today : $24.49 — upside +22%
🎯 on ELAN : no call matured yet · 📊 on Health : 32.6% · -10.5% (43 calls)
in progress (365j)
matures : Aug 6, 27
matures : Aug 6, 27
Morgan Stanley ↗
Jul 22, 26
■ Equal-Weight neutral · not a buy · 🎯$26
Price at call : $24.78 — gap to target +5%
Today : $24.49 — gap to target +6%
🎯 on ELAN : 0% (1 call matured) · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : Jul 22, 27
matures : Jul 22, 27
▲ Buy · 🎯$32
Price at call : $23.9 — upside +34%
Today : $24.49 — upside +31%
🎯 on ELAN : no call matured yet · 📊 on Health : 53.8% · +17.8% (26 calls)
in progress (365j)
matures : Jun 18, 27
matures : Jun 18, 27
▲ Buy · 🎯$31
Price at call : $23.65 — upside +31%
Today : $24.49 — upside +27%
🎯 on ELAN : no call matured yet · 📊 on Health : 56% · +15.7% (125 calls)
in progress (365j)
matures : May 7, 27
matures : May 7, 27
▲ Overweight · 🎯$30
Price at call : $23.65 — upside +27%
Today : $24.49 — upside +22%
🎯 on ELAN : no call matured yet · 📊 on Health : 49.3% · +6.2% (142 calls)
in progress (365j)
matures : May 7, 27
matures : May 7, 27
▲ Buy · 🎯$30
Price at call : $23.13 — upside +30%
Today : $24.49 — upside +22%
🎯 on ELAN : no call matured yet · 📊 on Health : 56% · +15.7% (125 calls)
in progress (365j)
matures : Apr 15, 27
matures : Apr 15, 27
Morgan Stanley ↗
Feb 25, 26
■ Equal-Weight neutral · not a buy · 🎯$24
Price at call : $26.19 — gap to target -8%
Today : $24.49 — gap to target -2%
🎯 on ELAN : 0% (1 call matured) · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
See the other 50 calls, newest to oldest
▲ Overweight · 🎯$29
Price at call : $26.19 — upside +11%
Today : $24.49 — upside +18%
🎯 on ELAN : no call matured yet · 📊 on Health : 32.6% · -10.5% (43 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
Leerink Partners ↗
Feb 24, 26
▲ Outperform · 🎯$30
Price at call : $26.84 — upside +12%
Today : $24.49 — upside +22%
🎯 on ELAN : 100% (1 call matured) · 📊 on Health : 54.5% · +10.0% (11 calls)
in progress (365j)
matures : Feb 24, 27
matures : Feb 24, 27
▲ Overweight · 🎯$28
Price at call : $24.98 — upside +12%
Today : $24.49 — upside +14%
🎯 on ELAN : no call matured yet · 📊 on Health : 49.3% · +6.2% (142 calls)
in progress (365j)
matures : Feb 19, 27
matures : Feb 19, 27
Piper Sandler ↗
Jan 22, 26
▲ Overweight · 🎯$30
Price at call : $24.91 — upside +20%
Today : $24.49 — upside +22%
🎯 on ELAN : no call matured yet · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Jan 22, 27
matures : Jan 22, 27
Morgan Stanley ↗
Dec 18, 25
■ Equal-Weight neutral · not a buy · 🎯$22
Price at call : $22.3 — gap to target -1%
Today : $24.49 — gap to target -10%
🎯 on ELAN : 0% (1 call matured) · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : Dec 18, 26
matures : Dec 18, 26
▲ Overweight · 🎯$30
Price at call : $21.3 — upside +41%
Today : $24.49 — upside +22%
🎯 on ELAN : 83% (6 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Dec 9, 26
matures : Dec 9, 26
▲ Overweight · 🎯$27
Price at call : $22.25 — upside +21%
Today : $24.49 — upside +10%
🎯 on ELAN : no call matured yet · 📊 on Health : 32.6% · -10.5% (43 calls)
in progress (365j)
matures : Nov 21, 26
matures : Nov 21, 26
▲ Buy · 🎯$27
Price at call : $21.49 — upside +26%
Today : $24.49 — upside +10%
🎯 on ELAN : 100% (4 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
in progress (365j)
matures : Nov 6, 26
matures : Nov 6, 26
▲ Buy · 🎯$25
Price at call : $21.62 — upside +16%
Today : $24.49 — upside +2%
🎯 on ELAN : 100% (4 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
in progress (365j)
matures : Oct 21, 26
matures : Oct 21, 26
▲ Overweight · 🎯$24
Price at call : $20.45 — upside +17%
Today : $24.49 — upside -2%
🎯 on ELAN : no call matured yet · 📊 on Health : 49.3% · +6.2% (142 calls)
in progress (365j)
matures : Oct 7, 26
matures : Oct 7, 26
▲ Buy · 🎯$23
Price at call : $18.92 — upside +22%
Today : $24.49 — upside -6%
🎯 on ELAN : 100% (8 calls matureds) · 📊 on Health : 48% · +12.4% (98 calls)
in progress (365j)
matures : Sep 24, 26
matures : Sep 24, 26
Piper Sandler ↗
Aug 11, 25
■ Neutral neutral · not a buy · 🎯$18
Price at call : $17.1 — gap to target +5%
Today : $24.49 — gap to target -27%
🎯 on ELAN : no call matured yet · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Aug 11, 26
matures : Aug 11, 26
▲ Buy · 🎯$19
Price at call : $17.1 — upside +11%
Today : $24.49 — upside -22%
Expected +11% · Actual +30% · Reason (≥ +15%) : ✓ Yes
🎯 on ELAN : 100% (4 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
+30.3%
stock +30% · XLV +29%
matured Aug 8, 26
▲ Buy · 🎯$18
Price at call : $14.69 — upside +23%
Today : $24.49 — upside -27%
Expected +23% · Actual +70% · Reason (≥ +15%) : ✓ Yes
🎯 on ELAN : 100% (4 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
+69.6%
stock +70% · XLV +20%
matured Jul 23, 26
Leerink Partners ↗
Jul 17, 25
▲ Outperform · 🎯$18
Price at call : $14.96 — upside +20%
Today : $24.49 — upside -27%
Expected +20% · Actual +73% · Reason (≥ +15%) : ✓ Yes
🎯 on ELAN : 100% (1 call matured) · 📊 on Health : 54.5% · +10.0% (11 calls)
+72.7%
stock +73% · XLV +21%
matured Jul 17, 26
▲ Buy · 🎯$17
Price at call : $14.64 — upside +16%
Today : $24.49 — upside -31%
Expected +16% · Actual +72% · Reason (≥ +15%) : ✓ Yes
🎯 on ELAN : 100% (8 calls matureds) · 📊 on Health : 48% · +12.4% (98 calls)
+71.7%
stock +72% · XLV +20%
matured Jul 2, 26
William Blair ↗
Jun 26, 25
▲ Outperform
Actual +72% · Reason (≥ +15%) : ✓ Yes
🎯 on ELAN : 100% (1 call matured) · 📊 on Health : 50% · +37.8% (20 calls)
+71.8%
stock +72% · XLV +19%
matured Jun 26, 26
▲ Buy · 🎯$16
Price at call : $13.08 — upside +22%
Today : $24.49 — upside -35%
Expected +22% · Actual +59% · Reason (≥ +15%) : ✓ Yes
🎯 on ELAN : 100% (8 calls matureds) · 📊 on Health : 48% · +12.4% (98 calls)
+59.4%
stock +59% · XLV +9%
matured May 19, 26
▲ Buy · 🎯$15
Price at call : $11.96 — upside +25%
Today : $24.49 — upside -39%
Expected +25% · Actual +82% · Reason (≥ +15%) : ✓ Yes
🎯 on ELAN : 100% (8 calls matureds) · 📊 on Health : 48% · +12.4% (98 calls)
+81.6%
stock +82% · XLV +8%
matured May 8, 26
▲ Buy · 🎯$13
Price at call : $8.24 — upside +58%
Today : $24.49 — upside -47%
Expected +58% · Actual +182% · Reason (≥ +15%) : ✓ Yes
🎯 on ELAN : 100% (8 calls matureds) · 📊 on Health : 48% · +12.4% (98 calls)
+181.9%
stock +182% · XLV +7%
matured Apr 14, 26
Piper Sandler ↗
Mar 6, 25
■ Neutral neutral · not a buy · 🎯$12
Price at call : $10.83 — gap to target +11%
Today : $24.49 — gap to target -51%
🎯 on ELAN : no call matured yet · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Mar 6, 26
matures : Mar 6, 26
▲ Buy · 🎯$17
Price at call : $10.92 — upside +56%
Today : $24.49 — upside -31%
Expected +56% · Actual +142% · Reason (≥ +15%) : ✓ Yes
🎯 on ELAN : 100% (4 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
+141.8%
stock +142% · XLV +9%
matured Feb 26, 26
Morgan Stanley ↗
Feb 26, 25
■ Equal-Weight neutral · not a buy · 🎯$13
Price at call : $10.92 — gap to target +19%
Today : $24.49 — gap to target -47%
🎯 on ELAN : 0% (1 call matured) · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : Feb 26, 26
matures : Feb 26, 26
▲ Buy · 🎯$15
Price at call : $11.13 — upside +35%
Today : $24.49 — upside -39%
Expected +35% · Actual +135% · Reason (≥ +15%) : ✓ Yes
🎯 on ELAN : 100% (8 calls matureds) · 📊 on Health : 48% · +12.4% (98 calls)
+135.3%
stock +135% · XLV +6%
matured Feb 26, 26
▲ Overweight · 🎯$19
Price at call : $11.13 — upside +71%
Today : $24.49 — upside -22%
Expected +71% · Actual +135% · Reason (≥ +15%) : ✓ Yes
🎯 on ELAN : 83% (6 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
+135.3%
stock +135% · XLV +6%
matured Feb 26, 26
▲ Buy · 🎯$16
Price at call : $11.11 — upside +44%
Today : $24.49 — upside -35%
Expected +44% · Actual +123% · Reason (≥ +15%) : ✓ Yes
🎯 on ELAN : 100% (8 calls matureds) · 📊 on Health : 48% · +12.4% (98 calls)
+122.8%
stock +123% · XLV +7%
matured Feb 21, 26
Morgan Stanley ↗
Jan 29, 25
■ Equal-Weight neutral · not a buy · 🎯$14
Price at call : $12.47 — gap to target +12%
Today : $24.49 — gap to target -43%
🎯 on ELAN : 0% (1 call matured) · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : Jan 29, 26
matures : Jan 29, 26
▲ Buy · 🎯$18
Price at call : $11.55 — upside +56%
Today : $24.49 — upside -27%
Expected +56% · Actual +101% · Reason (≥ +15%) : ✓ Yes
🎯 on ELAN : 100% (8 calls matureds) · 📊 on Health : 48% · +12.4% (98 calls)
+101.2%
stock +101% · XLV +13%
matured Jan 7, 26
▲ Buy · 🎯$18
Price at call : $12.88 — upside +40%
Today : $24.49 — upside -27%
Expected +40% · Actual +59% · Reason (≥ +15%) : ✓ Yes
🎯 on ELAN : 100% (4 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
+58.6%
stock +59% · XLV +4%
matured Dec 9, 25
Leerink Partners ↗
Dec 2, 24
■ Market Perform neutral · not a buy · 🎯$14
Price at call : $13.48 — gap to target +4%
Today : $24.49 — gap to target -43%
🎯 on ELAN : 100% (1 call matured) · 📊 on Health : 54.5% · +10.0% (11 calls)
in progress (365j)
matures : Dec 2, 25
matures : Dec 2, 25
▲ Overweight · 🎯$20
Price at call : $14.27 — upside +40%
Today : $24.49 — upside -18%
Expected +40% · Actual +56% · Reason (≥ +15%) : ✓ Yes
🎯 on ELAN : 83% (6 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
+56.1%
stock +56% · XLV -1%
matured Nov 8, 25
▲ Overweight · 🎯$19
Price at call : $12.51 — upside +52%
Today : $24.49 — upside -22%
Expected +52% · Actual +81% · Reason (≥ +15%) : ✓ Yes
🎯 on ELAN : 83% (6 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
+80.6%
stock +81% · XLV -3%
matured Oct 28, 25
▲ Overweight · 🎯$22
Price at call : $13.88 — upside +59%
Today : $24.49 — upside -10%
Expected +59% · Actual +35% · Reason (≥ +15%) : ✓ Yes
🎯 on ELAN : 83% (6 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
+35.1%
stock +35% · XLV -11%
matured Sep 23, 25
▲ Buy · 🎯$20
Price at call : $14.07 — upside +42%
Today : $24.49 — upside -18%
Expected +42% · Actual +35% · Reason (≥ +15%) : ✓ Yes
🎯 on ELAN : 100% (8 calls matureds) · 📊 on Health : 48% · +12.4% (98 calls)
+35.3%
stock +35% · XLV -12%
matured Sep 19, 25
Morgan Stanley ↗
Sep 19, 24
■ Equal-Weight neutral · not a buy · 🎯$15
Price at call : $15.07 — gap to target -0%
Today : $24.49 — gap to target -39%
🎯 on ELAN : 0% (1 call matured) · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : Sep 19, 25
matures : Sep 19, 25
Piper Sandler ↗
Jul 1, 24
■ Neutral neutral · not a buy · 🎯$16
Price at call : $14.1 — gap to target +13%
Today : $24.49 — gap to target -35%
🎯 on ELAN : no call matured yet · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Jul 1, 25
matures : Jul 1, 25
▲ Overweight · 🎯$21
Price at call : $14.1 — upside +49%
Today : $24.49 — upside -14%
Expected +49% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on ELAN : 83% (6 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
+1.3%
stock +1% · XLV -7%
matured Jun 28, 25
Piper Sandler ↗
May 13, 24
■ Neutral neutral · not a buy · 🎯$19
Price at call : $17 — gap to target +12%
Today : $24.49 — gap to target -22%
🎯 on ELAN : no call matured yet · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : May 13, 25
matures : May 13, 25
▲ Overweight · 🎯$23
Price at call : $17 — upside +35%
Today : $24.49 — upside -6%
Expected +35% · Actual -25% · Reason (≥ +15%) : ✗ No
🎯 on ELAN : 83% (6 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
-24.6%
stock -25% · XLV -5%
matured May 9, 25
Piper Sandler ↗
Mar 12, 24
■ Neutral neutral · not a buy · 🎯$18
Price at call : $15.91 — gap to target +13%
Today : $24.49 — gap to target -27%
🎯 on ELAN : no call matured yet · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Mar 12, 25
matures : Mar 12, 25
Goldman Sachs ↗
Feb 27, 24
▼ Sell · 🎯$14
Price at call : $15.93 — upside -12%
Today : $24.49 — upside -43%
Expected -12% · Actual -31% · Reason (≤ −15%) : ✓ Yes
🎯 on ELAN : 44% (9 calls matureds) · 📊 on Health : 57.9% · +13.8% (107 calls)
+31.4%
stock -31% · XLV +1%
matured Feb 26, 25
Morgan Stanley ↗
Feb 27, 24
▲ Overweight · 🎯$17
Price at call : $15.93 — upside +7%
Today : $24.49 — upside -31%
Expected +7% · Actual -31% · Reason (≥ +15%) : ✗ No
🎯 on ELAN : 0% (1 call matured) · 📊 on Health : 41.3% · -1.5% (196 calls)
-31.4%
stock -31% · XLV +1%
matured Feb 26, 25
Goldman Sachs ↗
Jan 17, 24
▼ Sell · 🎯$12.5
Price at call : $14.8 — upside -16%
Today : $24.49 — upside -49%
Expected -16% · Actual -19% · Reason (≤ −15%) : ✓ Yes
🎯 on ELAN : 44% (9 calls matureds) · 📊 on Health : 57.9% · +13.8% (107 calls)
+18.8%
stock -19% · XLV +1%
matured Jan 16, 25
Goldman Sachs ↗
Aug 9, 23
▼ Sell · 🎯$9.5
Price at call : $12.22 — upside -22%
Today : $24.49 — upside -61%
Expected -22% · Actual +7% · Reason (≤ −15%) : ✗ No
🎯 on ELAN : 44% (9 calls matureds) · 📊 on Health : 57.9% · +13.8% (107 calls)
-6.7%
stock +7% · XLV +11%
matured Aug 8, 24
Goldman Sachs ↗
Aug 8, 23
▼ Sell · 🎯$9.5
Price at call : $12.27 — upside -23%
Today : $24.49 — upside -61%
Expected -23% · Actual +6% · Reason (≤ −15%) : ✗ No
🎯 on ELAN : 44% (9 calls matureds) · 📊 on Health : 57.9% · +13.8% (107 calls)
-5.9%
stock +6% · XLV +11%
matured Aug 7, 24
Goldman Sachs ↗
Apr 26, 23
▼ Sell · 🎯$9
Price at call : $9.25 — upside -3%
Today : $24.49 — upside -63%
Expected -3% · Actual +41% · Reason (≤ −15%) : ✗ No
🎯 on ELAN : 44% (9 calls matureds) · 📊 on Health : 57.9% · +13.8% (107 calls)
-41.0%
stock +41% · XLV +6%
matured Apr 25, 24
Goldman Sachs ↗
Apr 25, 23
▼ Sell · 🎯$9
Price at call : $9.33 — upside -4%
Today : $24.49 — upside -63%
Expected -4% · Actual +43% · Reason (≤ −15%) : ✗ No
🎯 on ELAN : 44% (9 calls matureds) · 📊 on Health : 57.9% · +13.8% (107 calls)
-42.7%
stock +43% · XLV +5%
matured Apr 24, 24
Goldman Sachs ↗
Nov 9, 22
▼ Sell · 🎯$12
Price at call : $12.26 — upside -2%
Today : $24.49 — upside -51%
Expected -2% · Actual -13% · Reason (≤ −15%) : ✗ No
🎯 on ELAN : 44% (9 calls matureds) · 📊 on Health : 57.9% · +13.8% (107 calls)
+12.9%
stock -13% · XLV -6%
matured Nov 9, 23
Goldman Sachs ↗
Jul 21, 22
▼ Sell · 🎯$19
Price at call : $20.6 — upside -8%
Today : $24.49 — upside -22%
Expected -8% · Actual -42% · Reason (≤ −15%) : ✓ Yes
🎯 on ELAN : 44% (9 calls matureds) · 📊 on Health : 57.9% · +13.8% (107 calls)
+41.6%
stock -42% · XLV +5%
matured Jul 21, 23
Goldman Sachs ↗
May 19, 22
▲ Buy · 🎯$32
Price at call : $23.24 — upside +38%
Today : $24.49 — upside +31%
Expected +38% · Actual -63% · Reason (≥ +15%) : ✗ No
🎯 on ELAN : 44% (9 calls matureds) · 📊 on Health : 57.9% · +13.8% (107 calls)
-63.4%
stock -63% · XLV +2%
matured May 19, 23
Frequently asked questions
Should I buy Elanco stock?
This isn't buy advice. For Elanco, the analyst consensus is "Buy", with an average price target of $30.50 (+25% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Elanco). We show the numbers — you decide.
Is it too late to buy Elanco? How high can it go?
The most bullish analyst target on Elanco is $33.00 (+35% above today's price); the average is $30.50. That's the upside they see. Check how reliable those analysts have actually been on Elanco on our site before trusting it.
Is Elanco still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 7 analysts have a real record on Elanco, the best hitting 100% over 2 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Elanco? The case for and against
The arguments for and against, one by one, from the numbers: why invest in ELAN (and why hesitate).
What has Elanco's past performance been?
Historical returns and a "how much if I had invested" calculator: ELAN performance & returns.
Are insiders buying ELAN stock?
Executives' and large holders' buys and sells, decoded: insider buying on ELAN.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX